Publications

Evidence of our team's scientific rigour and commitment to medical advancement can be found in our extensive library of Niche Publications. We believe that sharing the results of our collaborative research is essential for fostering innovation and improving patient outcomes.

This resource brings together our peer reviewed papers, conference presentations, and technical posters, showcasing our deep expertise across a broad range of therapeutic areas from cardiovascular endocrinology to complex frailty studies. By making our published work accessible, we aim to contribute to the global scientific dialogue and provide our partners with a transparent look at the high standard clinical and analytical thinking that underpins every Niche project.

Explore our bibliography to see how we are helping to shape the future of medicine.

Acknowledged Publications

Recognised contributions to world-class research

A selection of peer-reviewed publications where Niche's scientific and clinical expertise has been formally acknowledged by research teams worldwide, reflecting the breadth and depth of our contribution to advancing medical knowledge.

Pharmacodynamics and pharmacokinetics of fluticasone furoate/vilanterol in healthy Chinese subjects

Written by

Chen X, Zheng X, Jiang J, Hu P, Wu K, Zhuang L, Liu L, Du X, Kempsford R, Allen A.

Explore The Publication

A phase 1, randomized, dose-ranging study of GS-5816, a once-daily NS5A inhibitor, in patients with genotype 1-4 hepatitis C virus

Written by

Lawitz E, Freilich B, Link J, German P, Mo H, Han L, Brainard DM, McNally J, Marbury T, Rodriguez-Torres M.

Explore The Publication

« Previous 1 … 12 13 14 15 16 … 58 Next »

Niche Manuscripts

Where our words shape the science

Publications where the Niche medical writing team played a central role in crafting the manuscript itself — translating complex clinical data into clear, compelling and submission-ready scientific communications.

EUFEMED London Conference 2017: Exploratory Medicines Development: Innovation and Risk Management

Written by

Van Bortel L, Sourgens H, Breithaupt-Grögler K, Caplain H, Donazzolo Y, Klingmann I, Hammond M, Hardman TC, Stringer S, de Hoon J.

Explore The Publication

A randomised pragmatic trial of corticosteroid optimization in severe asthma using a composite biomarker algorithm to adjust corticosteroid dose versus standard care: study protocol for a randomised trial

Written by

Hanratty CE, Matthews JG, Arron JR, Choy DF, Pavord ID, Bradding P, Brightling CE, Chaudhuri R, Cowan DC, Djukanovic R, Gallagher N, Fowler SJ, Hardman TC, Harrison T, Holweg CT, Howarth PH, Lordan J, Mansur AH, Menzies-Gow A, Mosesova S, Niven RM, Robinson DS, Shaw DE, Walker S, Woodcock A, Heaney LG; RASP-UK (Refractory Asthma Stratification Programme) Consortium.

Explore The Publication

« Previous 1 … 12 13 14 15 16 … 47 Next »

Publications

Acknowledged Publications

Pharmacodynamics and pharmacokinetics of fluticasone furoate/vilanterol in healthy Chinese subjects

A phase 1, randomized, dose-ranging study of GS-5816, a once-daily NS5A inhibitor, in patients with genotype 1-4 hepatitis C virus

Niche Manuscripts

EUFEMED London Conference 2017: Exploratory Medicines Development: Innovation and Risk Management

A randomised pragmatic trial of corticosteroid optimization in severe asthma using a composite biomarker algorithm to adjust corticosteroid dose versus standard care: study protocol for a randomised trial

Hi ✋